ABCAM Plc Director Declaration (9875N)
May 21 2015 - 1:10PM
UK Regulatory
TIDMABC
RNS Number : 9875N
ABCAM Plc
21 May 2015
For immediate release 21 May 2015
ABCAM PLC
("Abcam" or "the Company")
Director Disclosure
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of protein research tools, makes the following disclosure
pursuant to paragraph (g) (v) of Schedule Two of the AIM Rules for
Companies.
KCP Youth, a charity upon which Sue Harris, a Director of the
Company, served as chair of trustees, was placed into members'
voluntary liquidation and was dissolved on 19 May 2015.
There are no other disclosures required in relation to paragraph
(g) (v) of Schedule Two of the AIM Rules for Companies.
For further information please contact:
+ 44 (0) 1223
Abcam 696 000
Jeff Iliffe, Chief Financial Officer
Laura Taylor, Investor Relations Manager
J.P.Morgan Cazenove - Nominated Adviser & Joint + 44 (0) 20 7742
Corporate Broker 4000
James Mitford / Alex Bruce - Nominated Adviser
+ 44 (0) 20 7418
Peel Hunt LLP - Joint Corporate Broker 8900
Clare Terlouw / Jock Maxwell MacDonald - Corporate
Broking
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science
research tools, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level and improving the understanding of health and
disease.
Abcam is committed to providing scientists with an extensive
choice of reagents and tools, with the most comprehensive, honest
and up-to-date datasheets and customer reviews, fast delivery and
helpful customer service & technical support. The Company's
catalogue evolves with scientific research trends and is growing
each year to provide customers with products to meet their research
needs. The range now includes primary and secondary antibodies,
proteins, peptides, lysates, biochemicals, immunoassays and other
kits. Abcam also supports its customers by hosting a range of
global scientific events, forums and webinars, providing
opportunities for scientists to get together and present their
work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary
offices enabling local services and multi-language support and
sells to over 100 countries. The Company was founded in 1998, and
now employs over 800 people. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNEAXSFAEPSEFF
Abcam (LSE:ABC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abcam (LSE:ABC)
Historical Stock Chart
From Sep 2023 to Sep 2024